{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:28Z","timestamp":1794745168386,"version":"4.9.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL167133A1"],"award-info":[{"award-number":["R01HL167133A1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010518","name":"Michigan State University College of Human Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007709","name":"Michigan State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119962","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:30:42Z","timestamp":1790800242000},"page":"119962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ogremorphin induces ferroptosis in primary human glioblastoma neurospheres"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-9089","authenticated-orcid":false,"given":"Aaron H.","family":"Wasserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Tikaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain F.","family":"Basrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-4548","authenticated-orcid":false,"given":"Ana C.","family":"deCarvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-6259","authenticated-orcid":false,"given":"Leif R.","family":"Neitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-8252","authenticated-orcid":false,"given":"Charles C.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 2","key":"10.1016\/j.biopha.2026.119962_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119962_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119962_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.biopha.2026.119962_bib4","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.3390\/cancers15174279","article-title":"Recurrent Glioblastoma: a Review of the Treatment Options","volume":"15","author":"Vaz-Salgado","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib6","article-title":"Tumor microenvironment in glioblastoma: current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.46439\/cancerbiology.5.066","article-title":"Proton sensing GPCR\u2019s: the missing link to Warburg\u2019s oncogenic legacy?","volume":"5","author":"Cornell","year":"2024","journal-title":"J. Cancer Biol."},{"key":"10.1016\/j.biopha.2026.119962_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1535073","article-title":"Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance","volume":"13","author":"D\u2019Aprile","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119962_bib9","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.celrep.2017.02.006","article-title":"Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression","volume":"18","author":"Kondo","year":"2017","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10585-019-09990-1","article-title":"Adaptation to chronic acidic extracellular pH elicits a sustained increase in lung cancer cell invasion and metastasis","volume":"37","author":"Sutoo","year":"2020","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"3","key":"10.1016\/j.biopha.2026.119962_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111956","article-title":"Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis","volume":"28","author":"Rolver","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-023-00468-1","article-title":"GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment","volume":"13","author":"Williams","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: Mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119962_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron Metabolism in Ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: Mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119962_bib16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting Ferroptosis to Iron Out Cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119962_bib17","first-page":"1","article-title":"Understanding the unique mechanism of ferroptosis: A promising therapeutic target","volume":"11","author":"Kong","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119962_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2025.102649","article-title":"Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies","volume":"36","author":"Mashayekhi","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.biopha.2026.119962_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119962_bib20","first-page":"1","article-title":"System Xc -\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119962_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/2915019","article-title":"RSL3 Drives Ferroptosis through NF-\u03baB Pathway Activation and GPX4 Depletion in Glioblastoma","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11011-022-00983-w","article-title":"Capsaicin induces redox imbalance and ferroptosis through ACSL4\/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells","volume":"38","author":"Hacioglu","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41467-023-36630-w","article-title":"Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism","volume":"14","author":"Upadhyayula","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41420-026-03108-9","article-title":"Dual inhibition of xCT and GGCT induces ferroptosis in glioblastoma cells by depleting cysteine and disrupting redox homeostasis","volume":"12","author":"Mori","year":"2026","journal-title":"Cell. Death Discov."},{"issue":"8","key":"10.1016\/j.biopha.2026.119962_bib25","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1007\/s12011-023-03930-7","article-title":"Boric Acid Increases Susceptibility to Chemotherapy by Targeting the Ferritinophagy Signaling Pathway in TMZ Resistant Glioblastoma Cells","volume":"202","author":"Hacioglu","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12264-024-01322-y","article-title":"Dysregulation of Iron Homeostasis Mediated by FTH Increases Ferroptosis Sensitivity in TP53-Mutant Glioblastoma","volume":"41","author":"Huan","year":"2025","journal-title":"Neurosci. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2026.119962_bib27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41556-026-01953-5","article-title":"Stress granules restrain ferroptosis by sequestering ferritin","volume":"28","author":"Ge","year":"2026","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13104-024-06900-x","article-title":"Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models","volume":"17","author":"Neitzel","year":"2024","journal-title":"BMC Res. Notes"},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.18632\/oncotarget.27457","article-title":"Patient-derived glioblastoma cultures as a tool for small-molecule drug discovery","volume":"11","author":"Ye","year":"2020","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.biopha.2026.119962_bib30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/acsmedchemlett.5b00128","article-title":"High-Throughput Screening of Patient-Derived Cultures Reveals Potential for Precision Medicine in Glioblastoma","volume":"6","author":"Quartararo","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2026.119962_bib31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41588-018-0105-0","article-title":"Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma","volume":"50","author":"deCarvalho","year":"2018","journal-title":"Nat. Genet."},{"issue":"83","key":"10.1016\/j.biopha.2026.119962_bib32","doi-asserted-by":"crossref","DOI":"10.3791\/51088","article-title":"Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry","author":"Hasselbach","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5455\/jice.20140123040224","article-title":"Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from Corydalis yanhusuo","volume":"3","author":"Zhao","year":"2014","journal-title":"J. Intercult. Ethnopharmacol."},{"issue":"6953","key":"10.1016\/j.biopha.2026.119962_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature01905","article-title":"Proton-sensing G-protein-coupled receptors","volume":"425","author":"Ludwig","year":"2003","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2026.119962_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10082050","article-title":"Proton-Sensing GPCRs in Health and Disease","volume":"10","author":"Sisignano","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2026.119962_bib36","first-page":"1","article-title":"Characterization of the Intracellular Acidity Regulation of Brain Tumor Cells and Consequences for Therapeutic Optimization of Temozolomide","volume":"12","author":"Tafech","year":"2023","journal-title":"Biol. (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib37","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1038\/s41598-025-88357-x","article-title":"Inhibition of GPR68 induces ferroptosis and radiosensitivity in diverse cancer cell types","volume":"15","author":"Neitzel","year":"2025","journal-title":"Sci. Rep."},{"issue":"11-12","key":"10.1016\/j.biopha.2026.119962_bib38","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-10414-2","article-title":"The ferroptotic effect of NRF2-GCLM signaling axis derived by radiotherapy of esophageal squamous cell cancer: The vivo study","volume":"15","author":"Nuerrula","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119962_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade9585","article-title":"NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8","volume":"9","author":"Anandhan","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119962_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"issue":"22","key":"10.1016\/j.biopha.2026.119962_bib42","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1158\/0008-5472.CAN-24-4207","article-title":"Lipid Composition Alters Ferroptosis Sensitivity","volume":"85","author":"Park","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","article-title":"NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression","volume":"68","author":"Chen","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2026.119962_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","article-title":"Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis","volume":"416","author":"Chang","year":"2018","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119962_bib45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2019.09.023","article-title":"Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt\u2019s Lymphoma","volume":"519","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2026.119962_bib46","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin Receptor Is a Specific Ferroptosis Marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119962_bib47","article-title":"Characteristics and Biomarkers of Ferroptosis","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119962_bib48","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2026.119962_bib49","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"7579","key":"10.1016\/j.biopha.2026.119962_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature15699","article-title":"Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65","volume":"527","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.biopha.2026.119962_bib51","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-23-0547","article-title":"Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer","volume":"29","author":"Cornwell","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119962_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.08.027","article-title":"Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma","volume":"179","author":"Tsilimigras","year":"2025","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315171","article-title":"Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment","volume":"20","author":"Berezovsky","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119962_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2026.1808752","article-title":"Inhibition of GPR68 induces ferroptosis in diffuse intrinsic pontine gliomas","volume":"16","author":"Neitzel","year":"2026","journal-title":"Front. Oncol."},{"issue":"7643","key":"10.1016\/j.biopha.2026.119962_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","article-title":"Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity","volume":"543","author":"Turner","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41568-024-00669-8","article-title":"Extrachromosomal DNA in cancer","volume":"24","author":"Yan","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119962_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1092705","article-title":"Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications","volume":"12","author":"Luo","year":"2023","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119962_bib58","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/cells12071001","article-title":"Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine","volume":"12","author":"El Harane","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib59","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/stem.15","article-title":"Neurosphere formation is an independent predictor of clinical outcome in malignant glioma","volume":"27","author":"Laks","year":"2009","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41419-024-06667-w","article-title":"Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells","volume":"15","author":"Ascenzi","year":"2024","journal-title":"Cell. Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02711-6","article-title":"Ioning out glioblastoma: Ferroptosis mechanisms and therapeutic frontiers","volume":"11","author":"Sun","year":"2025","journal-title":"Cell. Death Discov."},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2020.11980","article-title":"Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis","volume":"20","author":"Tan","year":"2020","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2026.119962_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20193314","article-title":"Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition","volume":"40","author":"Yi","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2026.119962_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2024\/8464817","article-title":"Capsaicin Enhances Temozolomide-Resistant Glioblastoma Cells\u2019 Chemosensitivity and Ferroptosis through FHOD1\/IRF2 Downregulation","volume":"2024","author":"Hacioglu","year":"2024","journal-title":"J. Food Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119962_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcmm.70529","article-title":"Boric Acid Suppresses Glioblastoma Cellular Survival by Regulating Ferroptosis via SOX10\/GPx4\/ACSL4 Signalling and Iron Metabolism","volume":"29","author":"Kilic","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41416-022-01800-y","article-title":"Targeting NQO1\/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth","volume":"127","author":"Zhan","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2026.119962_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"22","key":"10.1016\/j.biopha.2026.119962_bib68","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.7150\/jca.58500","article-title":"FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"issue":"13","key":"10.1016\/j.biopha.2026.119962_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23136879","article-title":"Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment","volume":"23","author":"de Souza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib70","first-page":"1","article-title":"The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.biopha.2026.119962_bib71","doi-asserted-by":"crossref","first-page":"36021","DOI":"10.18632\/oncotarget.8651","article-title":"Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema","volume":"7","author":"Sehm","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119962_bib72","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jconrel.2024.01.004","article-title":"NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment","volume":"368","author":"Xue","year":"2024","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2026.119962_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-023-02095-6","article-title":"Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor","volume":"40","author":"Zhu","year":"2023","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119962_bib74","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","article-title":"Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells","volume":"148","author":"Song","year":"2022","journal-title":"J. Pharmacol. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2026.119962_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcmm.70188","article-title":"Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins","volume":"28","author":"Teng","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119962_bib76","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3349\/ymj.2021.62.9.843","article-title":"Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells","volume":"62","author":"Song","year":"2021","journal-title":"Yonsei Med. J."},{"issue":"16","key":"10.1016\/j.biopha.2026.119962_bib77","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-22-3971","article-title":"The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma","volume":"29","author":"Shi","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119962_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155631","article-title":"Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1\/HSPB1\/NCOA4","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.biopha.2026.119962_bib79","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-025-01729-0","article-title":"Ferroptosis-inducing effects of cromolyn in microglia through NCOA4-mediated ferritinophagy","volume":"40","author":"Kilic","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-023-01753-y","article-title":"Ferritinophagy: Research advance and clinical significance in cancers","volume":"9","author":"Wang","year":"2023","journal-title":"Cell. Death Discov."},{"issue":"4","key":"10.1016\/j.biopha.2026.119962_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2021.109024","article-title":"Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth","volume":"35","author":"Sighel","year":"2021","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41420-026-03072-4","article-title":"Targeting glioblastoma mitochondrial metabolism with S-Gboxin induces cytotoxicity under conditions of the tumor microenvironment","volume":"12","author":"Weinem","year":"2026","journal-title":"Cell. Death Discov."},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-026-04742-6","article-title":"MitoQ Triggers Mitochondrial Collapse and Apoptotic Death in Glioblastoma Associated with KATP Channel Expression Changes","volume":"51","author":"Karaaslan","year":"2026","journal-title":"Neurochem. Res."},{"issue":"14","key":"10.1016\/j.biopha.2026.119962_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.71301","article-title":"KATP Channel Expression Determines ONC212 Sensitivity via Mitochondrial Dysfunction and PERK\/ATF4\/CHOP Activation in Glioblastoma","volume":"30","author":"Taskesen","year":"2026","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119962_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1934-1","article-title":"ER stress and UPR activation in glioblastoma: Identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation","volume":"10","author":"Pe\u00f1aranda-Fajardo","year":"2019","journal-title":"Cell. Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119962_bib86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1096\/fba.2022-00141","article-title":"Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy","volume":"5","author":"Dowdell","year":"2023","journal-title":"FASEB BioAdvances"},{"key":"10.1016\/j.biopha.2026.119962_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2023.115867","article-title":"Dual targeting agent Thiotert inhibits the progression of glioblastoma by inducing ER stress-dependent autophagy","volume":"170","author":"Dong","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.biopha.2026.119962_bib88","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/ph17081089","article-title":"The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells","volume":"17","author":"Kusaczuk","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.biopha.2026.119962_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201809034","article-title":"Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization","volume":"11","author":"Le Joncour","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119962_bib90","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/jcb.29437","article-title":"Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma","volume":"121","author":"Zhou","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.2019102030","article-title":"Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis","volume":"39","author":"Jacobs","year":"2020","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.biopha.2026.119962_bib92","article-title":"Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma","volume":"5","author":"Zhong","year":"2024","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119962_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-56946-z","article-title":"Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma","volume":"16","author":"Jing","year":"2025","journal-title":"Nat. Commun."},{"issue":"34","key":"10.1016\/j.biopha.2026.119962_bib94","doi-asserted-by":"crossref","first-page":"23532","DOI":"10.18632\/oncotarget.25247","article-title":"Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model","volume":"9","author":"Doan","year":"2018","journal-title":"Oncotarget"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:56:03Z","timestamp":1794743763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":94,"alternative-id":["S0753332226009984"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119962","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ogremorphin induces ferroptosis in primary human glioblastoma neurospheres","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119962"}}